Corrigendum to "Discovery of indazole inhibitors for heat shock protein 90 as anti-cancer agents" [Eur. J. Med. Chem. (2024) 116620]

Affiliations

• ¹ College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
• ² Faculty of Pharmacy & PHENIKAA Institute for Advanced Study (PIAS), PHENIKAA University, Hanoi, 12116, Viet Nam.
• ³ Faculty of Pharmaceutical Chemistry and Technology, Hanoi University of Pharmacy, Hanoi, 10000, Viet Nam.
• ⁴ School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, 16419, Republic of Korea.
• ⁵ Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University, Seoul, 152-703, Republic of Korea; Department of Biomedical Research Center, Korea University Guro Hospital, Korea University, Seoul, 152-703, Republic of Korea; Brain Korea 21 Program for Biomedical Science, Korea University College of Medicine, Korea University, Seoul, 152-703, Republic of Korea.
• ⁶ Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University, Seoul, 152-703, Republic of Korea; Department of Biomedical Research Center, Korea University Guro Hospital, Korea University, Seoul, 152-703, Republic of Korea.
• ⁷ College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea. Electronic address: jihuya@gmail.com.
• ⁸ Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University, Seoul, 152-703, Republic of Korea; Department of Biomedical Research Center, Korea University Guro Hospital, Korea University, Seoul, 152-703, Republic of Korea; Brain Korea 21 Program for Biomedical Science, Korea University College of Medicine, Korea University, Seoul, 152-703, Republic of Korea. Electronic address: cancer@korea.ac.kr.
• ⁹ College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea. Electronic address: jeewoo@snu.ac.kr.